Cargando…
Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
The cardiovascular (CV) benefit and safety of treating low testosterone conditions is a matter of debate. Although testosterone deficiency has been linked to a rise in major adverse CV events, most of the studies on testosterone replacement therapy were not designed to assess CV risk and thus exclud...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087565/ https://www.ncbi.nlm.nih.gov/pubmed/33616800 http://dx.doi.org/10.1007/s11154-021-09628-2 |